Earn points on every order · Free shipping on orders over $159 · New products in stock
← Back to Compound Library
Reproductive and Hormonal

Kisspeptin-10

Tells your pituitary to fire off LH and FSH, which restarts your natural hormone system. Has to be dosed in pulses (like M/W/F), daily shuts it down.

Research referenceCommunity compiled
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Tells your pituitary to fire off LH and FSH, which restarts your natural hormone system.

Has to be dosed in pulses (like M/W/F), daily shuts it down.

What It Does

HPG axis activator, stimulates GnRH release to naturally drive testosterone, FSH, and libido through the body’s own hormonal cascade.

Activates GPR54 in the hypothalamus, triggering GnRH → LH + FSH surge → testosterone.

Reconstitution

Vial SizeBAC Water / SolventConcentration
5 mg+ 1 mL5 mg/mL
10 mg+ 2 mL5 mg/mL
Interactive tool

Reconstitution Calculator

Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.

Calculated concentration—Enter both values above.
Optional conversion

Enter a target amount you already have and select the syringe capacity.

Calculated draw—Enter concentration inputs and a target amount.

Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.

Protocol

PhaseFrequencyAmountNotes
StandardM/W/F100–2003.0–6.0u Community standard SubQ bolus. Daily dosing causes GPR54 desensitisation; pulsatile cadence
FertilityM/W/F or200–4006.0–12.0u HPG restoration. Higher dose for stronger LH/FSH surge. Avoid daily dosing.
Off30 days–– Natural HPG reset.
Cycle & Timing

30-day cycles, 30-day off.

Timing

3×/week SubQ pulsatile, never daily (GPR54 desensitization). Dose note: human IV data (George 2011) shows max LH at ~1 µg/kg (~70 mcg/70 kg); ~3 µg/kg gave a reduced response. SubQ bioavailability differs, so don’t escalate past observed LH/libido response.

Population Considerations

The LH/FSH response is hugely cycle-dependent, over 100× stronger just before ovulation. Timing is everything. Men: Raises LH and testosterone and speeds LH pulses, investigational for low-T and low lib The LH/FSH response is hugely cycle-dependent, over 100× stronger just before ovulation. Timing is everything. Men: Raises LH and testosterone and speeds LH pulses, investigational for low-T and low libido.

Handling & Stacking

Injection site
Abdomen or outer thigh.
Storage
  • Freeze-dried: -4°F.
  • Reconstituted: 36–46°F.
  • Best used within ~2–3 weeks (structure-based estimate, no published data); potency fades before the 28-day sterility limit, so keep it cold and dark and use it sooner.
Side effects
Testosterone surge symptoms. LH/FSH monitoring required.
What to expect
Testosterone and LH/FSH rise within days. Full HPG restoration takes 30+ days. Libido enhancement within 1–2 weeks. Supply math 5mg → 1 vial | 10mg → 1 vial (4-wk @ 200 mcg × 3/wk)
Pairs well with
HCG (additive HPG stimulation); CJC-1295 No DAC + Ipamorelin (anabolic environment); BPC-157 / TB-500 (recovery during cycle); PT-141 (sexual response synergy)
Avoid
Used too frequently, GPR54 desensitisation. Hormone-sensitive cancers. Pregnancy
Approved drug
Approved fertility options: clomiphene, hCG, injectable gonadotropins (FSH/hMG).

Safety & Patient Education

Contraindications
Hormone-sensitive malignancy (prostate cancer outside intentional ADT, breast cancer, ovarian cancer) Active thromboembolic disease Untreated thrombophilia Pregnancy (except specific fertility indications under specialist supervision) Polycythemia vera
Warnings
  • Estradiol elevation possible; AI may be needed.
  • Thromboembolic risk with elevated E2.
  • OHSS in females can be life-threatening.
  • Mood changes, gynecomastia in males.
  • Daily dosing causes GPR54 desensitization, pulsatile dosing only.
Drug interactions
  • AIs (anastrozole, letrozole): manage E2; over-suppression worsens lipids/bone.
  • SERMs (clomiphene, tamoxifen, enclomiphene): redundant HPG overlap.
  • Exogenous testosterone: shuts down LH/FSH, reduces efficacy unless TRT paused/microdosed.
  • Anticoagulants: elevated E2 raises thrombotic risk.
  • Insulin/antidiabetics: monitor glucose at high doses.
Labs
  • Total + free testosterone (baseline + end), LH + FSH (Day 0/10/30), sensitive E2 (baseline/mid/end); SHBG + prolactin baseline; CBC + hematocrit; lipid panel; PSA (men >40); semen analysis baseline + quarterly (fertility); D-dimer if clotting symptoms., Out of range?
  • Low testosterone or high estradiol = the hormone axis needs tuning; hematocrit >54% = blood too thick (donate or hold).
Stop criteria
Hematocrit >54% (donate/hold); E2 persistently above target despite AI; OHSS (distension, weight gain, dyspnea); thrombosis (calf swelling, chest pain, dyspnea, neuro); new breast tenderness/growth.
Patient education
  • Watch for clotting symptoms (leg swelling, calf/chest pain, sudden dyspnea).
  • Estrogen side effects manageable with an AI under physician guidance.
  • Fertility: 70+ days before semen analysis changes.
  • 3×/week maximum, avoid daily dosing (GPR54 desensitization).
References
researchdosing · peptidedosages · PubMed · thepeptidereport · peptides.id · Abbara 2015